The given sequence checksum does not match our current record for P0DOY2!
P0DOY2 (IGLC2_HUMAN) Homo sapiens (Human)
Immunoglobulin lambda constant 2 UniProtKBInterProInteractive Modelling
106 aa; Sequence (Fasta) ;
1 identical sequence: Cyprinus carpio: A0A8C2EAA3
It is possible new templates exist for this target since these models were created.
Available Structures
21 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| THREE-DIMENSIONAL STRUCTURE OF A HUMAN FAB WITH HIGH AFFINITY FOR TETANUS TOXOID |
Heteromer P01857; | |||||
| Assess | ||||||
| Bovine Fab 4C1 |
Heteromer P0DOX5; | 2×PO4; | ||||
| Assess | ||||||
| Bovine Fab 2G3 |
Heteromer P0DOX5; | 3×GOL; 1×MES; | ||||
| Assess | ||||||
| Antibody Fab fragment 447-52D in complex with UG1033 peptide |
Heteromer Q9YWB6; | |||||
| Assess | ||||||
| Bovine Fab 5C1 |
Heteromer P0DOX5; | 3×GOL; 1×PO4; | ||||
| Assess | ||||||
| Structural basis for specific inhibition of extracellular activation of pro/latent myostatin by SRK… |
Heteromer O14793; Q5EFE5; | 1×GOL; | ||||
| Assess | ||||||
| Bovine Fab SKD in complex with Sars COV-2 receptor binding domain |
Heteromer P0DOX5; P0DTC2; | 1×NAG; | ||||
| Assess | ||||||
| Bovine Fab 2F12 |
Heteromer P0DOX5; | |||||
| Assess | ||||||
| Crystal structure of Pertuzumab Clambda Fab with variable domain redesign (VRD2) at 1.95A |
Heteromer S6B291; | 4×SO4; | ||||
| Assess | ||||||
| Structure of Pertuzumab Fab with light chain Clambda at 2.16A |
Heteromer S6C4R2; | 1×SO4; 1×ACT; | ||||
| Assess | ||||||
| Fab fragment in complex with small molecule hapten, crystal form-1 |
Heteromer | 1×T5C; | ||||
| Assess | ||||||
| Fab fragment in complex with small molecule hapten, crystal form-2 |
Heteromer | 2×T5C; | ||||
| Assess | ||||||
| Crystal Structure at 4.3 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env T… |
Heteromer P01857; P04578; Q2N0S6; | 6×NAG; 3×NAG; 3×NAG; 24×NAG; 3×NAG; 3×NAG; 3×NAG; 18×NAG; 3×SO4; | ||||
| Assess | ||||||
| Crystal structure of Pertuzumab Clambda Fab with variable and constant domain redesigns (VRD2 and C… |
Heteromer S6B291; | 2×GOL; 1×MG; | ||||
| Assess | ||||||
| Crystal structure of a disease-associated anti-human GM-CSF autoantibody MB007 |
Heteromer P01857; | |||||
| Assess | ||||||
| Crystal structure of broad and potent HIV-1 neutralizing antibody PGT128 in complex with a glycosyl… |
Heteromer P01857; P04578; Q75760; | 1×NAG; 1×NAG; | ||||
| Assess | ||||||
| Structure of wild-type IgG1 antibody heavy chain constant domain 1 and light chain lambda constant … |
Heteromer P01857; | |||||
| Assess | ||||||
| Structure of redesigned IgG1 first constant and lambda domains (CH1:Clambda constant redesign 2 bet… |
Heteromer P01857; | 1×PG6; | ||||
| Assess | ||||||
| Structure of redesigned IgG1 first constant and lambda domains (CH1:Clambda constant redesign 1, CR… |
Heteromer P01857; | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HUMAN IMMUNOGLOBULIN FRAGMENT FAB NEW REFINED AT 2.0 ANGSTROMS RESOLUTION |
Heteromer P01825; | |||||
| Assess | ||||||
| BENCE JONES PROTEIN CLE, A LAMBDA III IMMUNOGLOBULIN LIGHT-CHAIN DIMER | homo-2-mer | |||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8ecv.1.A | monomer | 0.87 | 100.00 | |||
| Assess | ||||||